2019
DOI: 10.1186/s40478-019-0801-8
|View full text |Cite
|
Sign up to set email alerts
|

Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities

Abstract: In this multi-institutional study we compiled a retrospective cohort of 86 posterior fossa tumors having received the diagnosis of cerebellar glioblastoma (cGBM). All tumors were reviewed histologically and subjected to array-based methylation analysis followed by algorithm-based classification into distinct methylation classes (MCs). The single MC containing the largest proportion of 25 tumors diagnosed as cGBM was MC anaplastic astrocytoma with piloid features representing a recently-described molecular tumo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
60
2
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 43 publications
(66 citation statements)
references
References 34 publications
3
60
2
1
Order By: Relevance
“…Special attention should be given to diffuse astrocytomas in the brainstem or cerebellum with histo logies corresponding to WHO grades 2, 3 and 4. Among infratentorial astrocytomas, the frequency of non-canonical IDH mutations is ~80%, in contrast with <10% in those of the supratentorial compartment 27,28 . Infratentorial diffuse gliomas therefore tend to be classified incorrectly if examined by IDH1 R132H immunohistochemistry only; accordingly, DNA sequencing for rare mutations in IDH1 and IDH2 is required.…”
Section: Integrated Histomolecular Classificationmentioning
confidence: 98%
See 1 more Smart Citation
“…Special attention should be given to diffuse astrocytomas in the brainstem or cerebellum with histo logies corresponding to WHO grades 2, 3 and 4. Among infratentorial astrocytomas, the frequency of non-canonical IDH mutations is ~80%, in contrast with <10% in those of the supratentorial compartment 27,28 . Infratentorial diffuse gliomas therefore tend to be classified incorrectly if examined by IDH1 R132H immunohistochemistry only; accordingly, DNA sequencing for rare mutations in IDH1 and IDH2 is required.…”
Section: Integrated Histomolecular Classificationmentioning
confidence: 98%
“…Infratentorial diffuse gliomas therefore tend to be classified incorrectly if examined by IDH1 R132H immunohistochemistry only; accordingly, DNA sequencing for rare mutations in IDH1 and IDH2 is required. In addition, infratentorial IDH-mutant astrocytomas have a loss of nuclear ATRX expression as well as MGMT promoter methylation in only ~50% of patients 27 , 28 .…”
Section: Integrated Histomolecular Classificationmentioning
confidence: 99%
“…DNA methylation, targeted next-generation sequencing (NGS) and RNA sequencing DNA (84) and RNA (53) were extracted from formalinfixed and paraffin-embedded (FFPE) target tumor tissue samples using the automated Maxwell system (Promega, Madison, WI, USA) [15,16]. DNA was analyzed using the Illumina Human Methylation 450 k or 850 k/EPIC BeadChip array as described [5,6,14,16,22,23]. Briefly, DNA methylation analyses were performed in R version 3.3.0 (R Development Core Team).…”
Section: Patient Populationmentioning
confidence: 99%
“…In total, 428,799 probes were kept for analysis. The t-distributed stochastic neighbor embedding (t-SNE) plots were computed via the R package Rtsne [5,16,23]. Copy number profiles were generated using the 'conumee' package for R. Using the "Heidelberg brain tumor classifier; v11b4" (www.molec ularn europ athol ogy.org;), highly characteristic methylation classes of 84 institutionally diagnosed CNS-PNET were established, for which correlations to the respective brain tumor entities in the WHO classification ("reference tumor set") were evident [5,6].…”
Section: Patient Populationmentioning
confidence: 99%
“…However, no incidence of cAA has been reported due to its' utmost scarcity. This is not surprising that literature dealing with malignant gliomas of the cerebellum mostly consists of cerebellar glioblastomas, including both pediatric and adult patients, and brainstem tumours involving cerebellum [5,8,11,15,17,21,32,34].…”
Section: Introductionmentioning
confidence: 99%